What is the recommended intramuscular (IM) treatment for acute psychosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intramuscular Treatment for Acute Psychosis

For acute psychotic agitation requiring immediate IM treatment, use either haloperidol 2-5 mg IM or olanzapine 10 mg IM as monotherapy, or combine haloperidol 5 mg IM with lorazepam 2 mg IM for more rapid sedation. 1, 2, 3

First-Line IM Options

Conventional Antipsychotic Monotherapy

  • Haloperidol 2-5 mg IM is FDA-approved for prompt control of acutely agitated psychotic patients with moderately severe to very severe symptoms. 2
  • Subsequent doses may be given as often as every hour, though 4-8 hour intervals are typically satisfactory. 2
  • If rapid sedation is specifically required, consider droperidol over haloperidol (though droperidol carries FDA black box warning for QT prolongation). 1

Atypical Antipsychotic Monotherapy

  • Olanzapine 10 mg IM is an effective alternative with better tolerability than conventional antipsychotics. 3, 4
  • Atypical antipsychotics cause fewer extrapyramidal symptoms, which is critical for future medication adherence. 5, 6

Benzodiazepine Monotherapy

  • Lorazepam or midazolam IM are effective as monotherapy for undifferentiated acute agitation. 1
  • This approach is particularly useful when the etiology of psychosis is unclear or when avoiding antipsychotic side effects is paramount. 1

Combination Therapy for Faster Control

  • The combination of haloperidol 5 mg IM plus lorazepam 2 mg IM may produce more rapid sedation than monotherapy in acutely agitated psychiatric patients. 1, 7
  • This combination addresses both psychotic symptoms and agitation simultaneously. 7

Critical Transition Strategy

  • Switch to oral medication as soon as practicable—within 12-24 hours following the last parenteral dose. 2
  • For oral transition, use the parenteral dose administered in the preceding 24 hours as an initial approximation of total daily oral dose. 2
  • Oral risperidone 2 mg plus lorazepam 2 mg is as effective as IM haloperidol plus lorazepam for cooperative patients and should be considered first-line to avoid IM administration entirely. 1, 7, 6

When IM Treatment is NOT Appropriate

  • Long-acting injectable antipsychotics should NOT be used for acute treatment—oral or short-acting IM medications are preferable when dosage flexibility is needed. 1
  • LAI treatment should only begin after improvement of acute symptoms. 1

Common Pitfalls to Avoid

  • Avoid excessive initial dosing—large doses don't hasten recovery but significantly increase side effects, particularly extrapyramidal symptoms that compromise future adherence. 8, 5
  • Don't use typical antipsychotics as first-line when atypical options are available, as extrapyramidal side effects reduce long-term medication acceptance. 5, 6
  • Rule out organic causes before administering antipsychotics—in atropine-like drug psychosis or certain organic psychoses, antipsychotics should be avoided entirely. 9
  • Monitor QTc interval when feasible, especially with droperidol or when combining multiple agents that prolong QT. 1, 10

Dosing Specifics for Maintenance After Acute Phase

  • Once acute symptoms improve (typically 4-6 weeks), target maintenance doses of risperidone 2 mg/day or olanzapine 7.5-10 mg/day. 8, 5
  • Maximum doses should not exceed risperidone 4 mg/day or olanzapine 20 mg/day in first-episode patients. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.